12:00 AM
 | 
Feb 02, 2009
 |  BC Week In Review  |  Company News  |  Deals

Helsinn, Sapphire deal

Helsinn acquired cancer company Sapphire for an undisclosed sum. Helsinn said the deal establishes R&D and commercial operations in the U.S. and expands its pipeline of products in cancer and gastrointestinal supportive care....

Read the full 145 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >